1. Baylor College of Medicine
  2. Healthcare
  3. Clinical Trials
  4. Results

Search for Clinical Trials

S1937: Comparing Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer (H-55301)
S1937: A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
MODERN (A032103): Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment (H-56225)
MODERN (A032103): An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcerThis phase II/III trial…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
BRIDGE Study (EA8212): Intravesical BCG vs GEMDOCE in non-muscle invasive bladder cancer (H-54036)
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer (H-52350)
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) to Determine the Feasibility and Safety of Intratumoral Injection With or Without…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
A031803: Testing the Addition of Pembrolizumab to Gemcitabine for BCG-Unresponsive Non-muscle Invasive Bladder Cancer (H-50373)
A031803: Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
Back to topback-to-top